Pre-operative treatment with Erythropoietin and iron supplement for prevention of perioperative blood transfusion in cardiac surgery

Completed

• Conditions: bloodloss in cardiac surgery; 10007593

• Registration Number: NL-OMON40254
• Lead Sponsor: Catharina-ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

1. Age of 18 years or more undergoing isolated CABG or AVR
2. Preoperative Hb < 7 mmol/l.

Exclusion Criteria

1. Off pump surgery.
2. Combination surgery.
3. Re-operation.
4. Emergency operation.
5. Patients with bleeding disturbances;e.g, hemophilia and patients with chronic liver disease.
6. Concomitant use of cyclosporine prior to, during or following surgery
7. Female patients who are pregnant or planning to become pregnant.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The number of patients who receive RBC transfusion perioperatively. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>The mean number of RBC units received per patient in the perioperative period.</p><br>